about
Human Uterine Cervical Stromal Stem Cells (hUCESCs): Why and How they Exert their Antitumor ActivityRelationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancerPotential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment.Matrix Metalloproteinases and Bladder Cancer: What is New?Comparative study: TQ and Lean Production ownership models in health services.Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.Importance of tumor/stroma interactions in prognosis of hepatocellular carcinoma.Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis.Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.Corneal epithelial wound healing and bactericidal effect of conditioned medium from human uterine cervical stem cells.Erratum to: Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer.Analysis of the expression of interleukins, interferon β, and nuclear factor-κ B in prostate cancer and their relationship with biochemical recurrence.Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.Toll-like receptor-4 expression by stromal fibroblasts is associated with poor prognosis in colorectal cancer.Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node.Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.Matrix metalloproteases expression in different histological types of colorectal polyps.Metalloproteinase 11, potential marker and molecular target in advanced and castration-resistant prostate cancer. Culture study of peritumoral fibroblasts.Stromal factors involved in human prostate cancer development, progression and castration resistance.Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.An adult myometrial pluripotential precursor that promotes healing of damaged muscular tissues.Clinical significance of myosin in colorectal cancer.Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer.Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.Relationship between breast arterial calcifications seen on screening mammograms and age-related macular degenerationCancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesisNon Pregnant Human Uterus as Source of Mesenchymal Stem CellsPrognostic significance of inflammatory factors expression by stroma from breast carcinomasRelationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancerMMP11 expression in intratumoral inflammatory cells in breast cancer
P50
Q28076434-894FADB7-4099-4E7F-B86D-DA8C5E79ACB9Q34473935-50456BF5-C5EA-4DDE-ABFD-62C736AB65BFQ34541239-F020D7ED-6D6D-49A6-843E-0A88B968B563Q34786543-B3ECAAD7-9186-4E2B-9DB1-F6F6DCE9B5FEQ35008756-06E91FE7-486B-44CE-8C0E-28CA7B4C49A3Q35798885-7349CC2B-A687-4C6F-9242-C61376CD25D7Q35987385-4725771D-F01E-48F2-8610-176A9530BB3EQ36125093-EEDB2579-89DE-4223-BBC7-9BE544FC7F30Q36320831-5BC26DB0-AA66-4196-AEEA-643F3C49C404Q38608414-7E2961E3-05E7-48C6-969F-9783B36A7695Q38628048-FA0D4AFA-84DE-4B71-9DAE-70C85EE2702FQ38836952-F83B066C-99E0-43B8-843C-7C056EEA6403Q38962017-B5BC84AC-2AA4-485F-BB33-7B277FFECC9AQ39629348-638C6456-D848-4D46-B451-B41B0B021153Q40716846-E300383E-AD49-49B9-B877-3AD48E3F1EBDQ41219034-482DC3E1-574E-47E8-887D-8F004081B04AQ41526161-D5BB4ABB-727A-4B4C-92D3-711003C19470Q42371699-6341CEEC-F581-4DCD-A9C4-130DFF522776Q44880467-A08D2760-21EE-49D9-BA79-0450E852ACDBQ45017596-6438C5EA-DFEB-44D6-B76F-88595D844B7EQ46150179-B1EA80DB-BE42-48F0-8A52-7DFC1711F0D3Q46427574-3E0A613D-C072-43B7-ACA7-184CFC063DA8Q46841019-17D3E305-D5BF-4C43-9B87-FCDB43369886Q47925738-D0939F95-E623-4CFF-B636-DC926649B2E2Q50015022-28B2589C-CC0B-4B73-BF78-58BB322A6C38Q50100841-C834E1DF-A5B8-46BD-9148-EF7D790FA8FBQ50750054-33F69AB0-2E66-48D6-A850-EB04E68DBDE5Q51153017-D17537CA-51E1-40CC-8740-B2FE8C6EB686Q51360042-71011B9D-5C32-475D-8EDA-DDF217B68693Q51872814-42D79E5E-C198-45AF-B984-918A6EA53781Q53309653-69F2EBC8-9ADE-4C61-82C5-B1FF8D23171EQ54317770-4724470A-176A-49E0-A805-C9AA990EB627Q54321617-25C9FC07-7C85-47EE-95B7-9857D4D9A68FQ54777883-8FD57054-3FFE-4612-A030-A1C9CEA8F9BEQ87180624-D3FBCB81-14C1-46CB-84FF-9BD2FDBA8664Q87934636-AE07F876-DA8A-4F2D-A0EE-B2BEAD721C01Q88490969-9010BEFD-4F98-4BF8-926C-E4AF2B1B6FE5Q89251612-F0DF6F05-127D-4CB8-983A-D79AFA65E80EQ89297377-1F3005E6-F287-4F17-90B6-8265F7851788Q92163015-F2B49DE2-171E-4C0C-9524-772DB02647E4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Noemí Eiró
@ast
Noemí Eiró
@en
Noemí Eiró
@es
Noemí Eiró
@nl
Noemí Eiró
@sl
type
label
Noemí Eiró
@ast
Noemí Eiró
@en
Noemí Eiró
@es
Noemí Eiró
@nl
Noemí Eiró
@sl
prefLabel
Noemí Eiró
@ast
Noemí Eiró
@en
Noemí Eiró
@es
Noemí Eiró
@nl
Noemí Eiró
@sl
P1053
C-9510-2018
P106
P31
P3829
P496
0000-0001-5840-4807